5,0
18. Okt. 2021
Aktueller Mitarbeiter
Empfehlen
CEO-Befürwortung
Geschäftsprognose
Pros
Company is developing molecular diagnostic assays based on a novel technology that will dramatically improve how diseases are diagnosed.
Kontras
There are not really any disadvantage